This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Filling More Than Just Prescriptions: London Drugs Selects Demandware For Multichannel Commerce

Demandware®, Inc. (NYSE: DWRE), a leader in on-demand ecommerce, today announced that London Drugs, a popular chain of Canadian retail stores serving more than 45 million customers each year, has selected Demandware to power its digital commerce strategy, starting with the relaunch of its Canadian ecommerce site. London Drugs will leverage Demandware’s multichannel commerce solution to integrate its web, mobile and in-store channels and extend the superior in-store shopping experience London Drugs is best known for across all digital channels.

Founded in 1945, London Drugs has stores in more than 35 major markets throughout British Columbia, Alberta, Saskatchewan, and Manitoba. In addition to pharmaceuticals, London Drugs sells electronics, computers, cameras, housewares, apparel, cosmetics and a limited selection of grocery items. The company is completely committed to customer satisfaction and providing customers with a superior shopping experience.

“London Drugs is dedicated to providing a superior shopping experience to customers every time they shop with us, whether it’s in one of our 75 physical stores or online,” said Clint Mahlman, London Drugs chief operating officer and senior vice president. “We look forward to welcoming our customers to the new Demandware-powered London Drugs revitalized online store, where they will experience improved navigation and functionality, and the ability to easily find and purchase an exciting array of products across multiple digital channels.”

London Drugs is focused on growth and innovation and strives to become a “go-to” website for Canadian customers. To achieve its goals, the retailer required a new platform that would enable customers to easily search and purchase goods across multiple digital touch points, including web, mobile phones and tablets, while also driving traffic to its physical locations throughout Western Canada.

London Drugs is replacing its legacy software platform with cloud-based Demandware Commerce because it provides the following benefits and capabilities:

  • A central commerce platform for developing and managing multiple branded sites across channels, including web, mobile and social
  • The ability to deliver an exceptional online user experience and customer service that is on par with its superior in-store experience and service
  • Powerful commerce applications that empower all users, including merchandisers, marketers, developers, designers, and operations, customer service and fulfillment teams
  • New features made available continually through automatic global releases
  • A scalable and secure commerce cloud infrastructure with state-of-the-art data centers, PCI compliance and industry-leading performance and uptime, readily available for London Drugs to plug into

“The London Drugs brand is synonymous with the impeccable customer service they provide throughout its stores. With Demandware, it can now extend that same outstanding brand experience to its customers across all digital commerce channels no matter where and when they shop. We’re delighted to have been chosen by London Drugs and look forward to working with them on their multichannel initiatives,” said Jamus Driscoll, senior VP of marketing for Demandware.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,067.56 -30.89 -0.18%
S&P 500 2,002.28 -1.09 -0.05%
NASDAQ 4,598.1880 +17.9170 0.39%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs